Reference : Sustained antihypertensive activity of telmisartan vs valsartan
Scientific congresses and symposiums : Poster
Human health sciences : Urology & nephrology
Sustained antihypertensive activity of telmisartan vs valsartan
Lacourciere, Yves mailto [CHU de Quebec, Quebec, Canada > > Métabolisme, santé vasculaire et rénale > >]
Krzesinski, Jean-Marie mailto [Université de Liège - ULiège > Département des sciences cliniques > Néphrologie >]
White, William [University of Connecticut - UCONN > School of Medicine > > >]
Davidai, Giora [Boerhringer Ingelheim Pharmaceutcals Inc., Ridgefield, Connecticut, USA > > > > > >]
Oostvogel, L. [Boehringer Ingelheim SA > > > >]
Schumacher, H. [Boehringer Ingelheim Pharma KG > > > >]
20th Scientific Meeting of the International Society of Hypertension
15-19 février 2004
International Society of Hypertension
Sao Paulo
[en] Hypertension ; telmisartan ; valsartan ; blood pressure control
[en] DBP reduction in the last 6 h of the once-daily dosing interval and 24-h mean DBP control when a dose is missed are significantly superior with telmisartan than with valsartan. Thus, telmisartan due to its longer half-life offers more sustained BP control, especially at the end of the dosing period and provides sustained efficacy in poorly compliant patients.

File(s) associated to this reference

Fulltext file(s):

Open access
J Hypertens 2004 22 suppl 1 S196 P724001.pdfPublisher postprint289.93 kBView/Open

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.